The LiaFSR system and antimicrobial peptide resistance in enterococci
$454,282R01FY2021AINIH
Methodist Hospital Research Institute, Houston TX
Investigators
Linked publications & trials
Paper 39405116Paper 39345182Paper 39203518Paper 39040169Paper 38995033Paper 38835498Paper 38831030Paper 38352536Paper 38334390Paper 38289081Paper 38289078Paper 38190524Paper 37738153Paper 37338398Paper 37338375Paper 37293062Paper 37162332Paper 36774938Paper 36649910Paper 36601551Paper 36541772Paper 36377664Paper 36322484Paper 36173830Paper 36036505Paper 35929656Paper 35543524Paper 35311529Paper 35155713Paper 35016207Paper 35007139Paper 34828256Paper 34780269Paper 34767753Paper 34723631Paper 34339274Paper 34125596Paper 34039880Paper 33536292Paper 33468468Paper 33421068Paper 33164081Paper 33131572Paper 32958711Paper 32824132Paper 32571816Paper 32562543Paper 32544947Paper 32514561Paper 32358872Paper 32221315Paper 32209565Paper 32152078Paper 32151332Paper 32122892Paper 32094136Paper 32071048Paper 31871075Paper 31818937Paper 31658962Paper 31332078Paper 31284042Paper 31281867Paper 31209457Paper 31119397Paper 31109795Paper 31080781Paper 30962347Paper 30938438Paper 30670435Paper 30582877Paper 30517150Paper 30509945Paper 30403130Paper 30339217Paper 30188976Paper 30186248Paper 29977970Paper 29941639Paper 29760141Paper 29547977Paper 29546356
View original record on NIH RePORTER →